MOVIN a joint venture between InterGlobe Enterprises and UPS has launched a dedicated healthcare logistics vertical offering end-to-end, temperature-controlled delivery for pharmaceuticals, MedTech, diagnostics and lab shipments, addressing a growing demand for safe, reliable transport of sensitive medical consignments across India.
Glimpse:
MOVIN Healthcare will support refrigerated (2–8 °C), ambient-controlled (15–25 °C), and deep-freeze dry-ice shipments (–80 to –20 °C), essential for vaccines, biologics, clinical-trial materials, diagnostics kits, and more. Shipments will be monitored 24/7 through a control-tower, with priority handling, real-time tracking, and comprehensive carrier-insurance. The service will initially cover 50 strategic markets, covering metropolitan, tier-II, and tier-III cities.
India’s fast-growing demand for safe, reliable supply of pharmaceuticals, biologics, diagnostics, MedTech devices, and clinical-trial materials has created an urgent need for high-quality healthcare logistics. Recognising this, MOVIN Express the JV between InterGlobe Enterprises and UPS today announced the launch of a specialised vertical: MOVIN Healthcare.
MOVIN Healthcare is built to handle complex, temperature-sensitive medical shipments: its packaging and logistics infrastructure supports a full range of temperature zones from refrigerated (2–8 °C) to ambient (15–25 °C), and even deep-freeze dry-ice (–80 to –20 °C) for ultra-cold shipments. This makes it suitable for transporting vaccines, biologics, temperature-sensitive drugs, diagnostic kits, reagents, MedTech equipment and clinical-trial materials.
To ensure integrity and reliability, every shipment is accompanied by end-to-end monitoring, a 24×7 control tower, priority handling, and comprehensive carrier insurance features often lacking in traditional logistics services. MOVIN also introduced a “Next Flight Out (NFO)” service tailored for time-critical medical consignments, promising expedited transport for emergency needs — such as urgent vaccine deliveries, transplant materials, or critical diagnostics shipments.
The initial rollout will cover 50 strategic markets, spanning not only metro cities but also tier-II and tier-III markets, which is key to ensuring equitable healthcare supply across urban and semi-urban/rural India. emphasise a patient-first approach. “It is not a package; it’s a patient for us,” said a senior company official underscoring the higher stakes when transporting medicines, biologics and diagnostics compared to regular cargo.
Given India’s rapidly expanding healthcare consumption, growth in vaccine and biologics manufacturing, expansion of diagnostics networks, and increasing participation in global clinical trials, MOVIN Healthcare’s entry signals a significant step toward professionalising and strengthening India’s medical supply-chain infrastructure.
“By building specialised temperature-controlled corridors, real-time monitoring and rapid-response logistics, we’re treating every shipment like a patient because in healthcare logistics, timing and integrity can make the difference between life and loss.”
By
HB Team
